First Trust Nasdaq Pharmaceuticals ETF
FTXH
$41.37
Updated: 22/09/2026, 13:27:38
Market Cap
$1.02B
Sector
Financial Services
Industry
Asset Management - Global
Country
US
Stock valuation chart
One-year closing share-price history for FTXH
Company Profile
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
USD
NASDAQ
Asset Summaries
Latest generated summaries for FTXH
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for FTXH.
- Share price
- $41.37
- Market cap
- $1.02B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 22/09/2016
- Beta
- 0.464
- Last dividend
- $0.00
- Day range
- $40.89 – $41.54
- 52-week range
- $27.30 – $42.87
- 1-day performance
- 0.67%
- 1-year performance
- 51.53%
- Current drawdown (1Y)
- -3.51%
- CIK
- 0001552740
- CUSIP
- 33738R837
- ISIN
- US33738R8372
- Created
- 07/12/2025, 04:08:03
- Last update
- 22/09/2026, 13:27:38
Track First Trust Nasdaq Pharmaceuticals ETF with an AI analyst
See which prediction-market events move FTXH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to FTXH from your Railway `news_articles` table.